Nick J Andrews
Salk Institute for Biological Studies
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Influenza Virus Research Studies
Strong evidence · 3 supporting papers · latest 2026
Respiratory viral infections research
Strong evidence · 9 supporting papers · latest 2026
Pneumonia and Respiratory Infections
Strong evidence · 3 supporting papers · latest 2026
SARS-CoV-2 detection and testing
Strong evidence · 1 supporting paper · latest 2026
SARS-CoV-2 and COVID-19 Research
Solid evidence · 3 supporting papers · latest 2026
COVID-19 Clinical Research Studies
Solid evidence · 2 supporting papers · latest 2026
Viral Infections and Immunology Research
Solid evidence · 1 supporting paper · latest 2026
Peripheral Neuropathies and Disorders
Solid evidence · 1 supporting paper · latest 2025
Publications (15)
Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England
2026DOIPMID 42471217
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026
2026DOIPMID 41716088
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K
2025DOIPMID 41267661
Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026
2026DOIPMID 42725370
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence
2026DOIPMID 41747754
Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 Seasons
2025DOIPMID 41307445
Long-term survival after invasive pneumococcal disease: a matched cohort study using electronic health records in England
2025DOIPMID 41285138
Assessing the risk of Guillain-Barré syndrome in older adults after bivalent RSV pre-F vaccination in England
2025DOIPMID 41381510
An observational, cohort, multi-centre, open label phase IV extension study comparing IPV immune responses to preschool dTaP-IPV booster vaccines in children whose mothers received or did not receive an IPV-containing pertussis vaccine during pregnancy in England
2026DOIPMID 41690287
Prevalence and impact of SARS-CoV-2, influenza, respiratory syncytial virus (RSV) infection and respiratory illness on UK healthcare workers during winter 2023/24 (September 2023 to March 2024): SIREN cohort study
2025DOIPMID 41045989
Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons
2026DOIPMID 41540002
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial
2026DOIPMID 42105778
Preclinical validation of AAV9-TECPR2 gene therapy in a novel knock-in model of TECPR2-related disorder
2026DOIPMID 41867828
The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000–2019
2026DOIPMID 42771940
Author response for "Effectiveness of influenza vaccines and duration of protection against hospitalisation in England: 2022/23 and 2023/24 seasons"
2025DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Salk Institute for Biological Studies
Source: OpenAlex · retrieved 2026-09-29